New article: Cost-effectiveness analysis of pembrolizumab compared to standard of care as first line treatment for patients with advanced melanoma in Hong Kong. https://t.co/ajf0scXs6U #melanoma #oncology
906 followers
1,227 followers
RT @herbloong: #Costeffectiveness (CE) analyses are important in healthcare decisions. Our work looking at CE of first-line #pembrolizumab…
1,487 followers
RT @herbloong: #Costeffectiveness (CE) analyses are important in healthcare decisions. Our work looking at CE of first-line #pembrolizumab…
3,663 followers
#Costeffectiveness (CE) analyses are important in healthcare decisions. Our work looking at CE of first-line #pembrolizumab vs. #ipilimumab & #cytotoxics in #melanoma in #hongkong setting has just been published! https://t.co/SWGpl4EaJG @CarlosWongHKU